Figure S3. Pathway enrichment by RNA-Seq. Dot plots showing the enrichment results of KEGG pathway analysis for KYSE450-R versus KYSE450-P (A), EC109-R versus EC109-P (B), and PDX03-R versus PDX03-P (C), as detected by RNA-seq. The size of the dots indicates the number of genes enriched in the corresponding pathways. The color of the dots indicates the significance level of the enriched pathways, as represented by the value of Padj. (DOCX 549 kb
Figure S4. Connectivity in the map between the 25 most frequently mutated genes and pathways. Simila...
Genes upregulated during liver metastasis; cancer and organ-specific changes. DESeq2 was used to ide...
Figure S3. JQ1 resulted in a greater reduction of tumor growth than sorafenib in vivo. (a) BEL-7402 ...
Figure S1. Efficacy of different EGFR blockers on ESCC cell lines and PDX models. (A) Six ESCC cell ...
Figure S2. Effects of afatinib on cell cycle and apoptosis in EC109 cells. EC109 cells were treated ...
miR-455-3p overexpression activates T-IC-associated signaling pathways. (A) GSEA analysis of TCGA da...
Effects of EGFR inhibition or activation on immortalized-human esophageal epithelial cells. EPC2-hTE...
Figure S4. (A)The potential signaling pathway contributed to imatinib resistance in GIST. The green ...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Additional file 1: Figure S1. ESRRA and ESRRB expression in paired samples of tumor tissues and nont...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Figure S2. GFP-positive cancer cells in ID8 and ID8-KRAS cells in vivo. Mice were i.p. injected with...
Figure S8. Comparison of significantly enriched KEGG pathway annotations in each of our analyses. Up...
Figure S4. Connectivity in the map between the 25 most frequently mutated genes and pathways. Simila...
Genes upregulated during liver metastasis; cancer and organ-specific changes. DESeq2 was used to ide...
Figure S3. JQ1 resulted in a greater reduction of tumor growth than sorafenib in vivo. (a) BEL-7402 ...
Figure S1. Efficacy of different EGFR blockers on ESCC cell lines and PDX models. (A) Six ESCC cell ...
Figure S2. Effects of afatinib on cell cycle and apoptosis in EC109 cells. EC109 cells were treated ...
miR-455-3p overexpression activates T-IC-associated signaling pathways. (A) GSEA analysis of TCGA da...
Effects of EGFR inhibition or activation on immortalized-human esophageal epithelial cells. EPC2-hTE...
Figure S4. (A)The potential signaling pathway contributed to imatinib resistance in GIST. The green ...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Additional file 1: Figure S1. ESRRA and ESRRB expression in paired samples of tumor tissues and nont...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Overview of the pathway analysis by DAVID. All genes with predictive pathogenic mutation were analys...
Figure S2. GFP-positive cancer cells in ID8 and ID8-KRAS cells in vivo. Mice were i.p. injected with...
Figure S8. Comparison of significantly enriched KEGG pathway annotations in each of our analyses. Up...
Figure S4. Connectivity in the map between the 25 most frequently mutated genes and pathways. Simila...
Genes upregulated during liver metastasis; cancer and organ-specific changes. DESeq2 was used to ide...
Figure S3. JQ1 resulted in a greater reduction of tumor growth than sorafenib in vivo. (a) BEL-7402 ...